Exagen Ownership 2024 | Who Owns Exagen Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

34.79%

Insider Ownership

28.31%

Retail Ownership

36.90%

Institutional Holders

32.00

Exagen Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RTW INVESTMENTS, LP8.44%0.04%1,504,602--2,392,317Mar 31, 2024
COWEN AND COMPANY, LLC5.04%0.06%898,630--1,428,821Mar 31, 2024
WASATCH ADVISORS LP4.41%0.01%786,895-63,413-7.46%1,251,163Mar 31, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC3.05%0.01%544,877--866,354Mar 31, 2024
PERKINS CAPITAL MANAGEMENT INC2.77%0.65%493,571-15,334-3.01%785,000Mar 31, 2024
VANGUARD GROUP INC2.75%-490,944--780,601Mar 31, 2024
MORGAN STANLEY2.70%0.00%482,420-1,500-0.31%767,048Mar 31, 2024
STONEPINE CAPITAL MANAGEMENT, LLC2.16%0.49%384,600-285,084-42.57%611,514Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.46%-81,583--129,757Mar 31, 2024
PENBROOK MANAGEMENT LLC0.43%0.08%76,7101,0001.32%121,969Mar 31, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.42%0.01%74,306-22,818-23.49%118,147Mar 31, 2024
UBS GROUP AG0.35%-62,5161070.17%99,400Mar 31, 2024
BLACKROCK INC.0.31%-55,505-2,330-4.03%88,253Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.27%0.00%48,7583,2707.19%78,000Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.23%0.00%40,800--64,872Mar 31, 2024
STATE STREET CORP0.16%-27,691-6,000-17.81%44,029Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.15%-26,437-9,593-26.63%42,035Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.13%-23,8602451.04%37,937Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.11%-19,8009,20086.79%31,482Mar 31, 2024
PALUMBO WEALTH MANAGEMENT LLC0.10%0.01%18,24118,241100.00%29,004Mar 31, 2024

Exagen's largest institutional shareholder is RTW INVESTMENTS, LP, holding 8.44% of the company's total share outstanding, currently valued at $2.39M. The top 10 institutional shareholders own together 32.21% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PERKINS CAPITAL MANAGEMENT INC2.77%0.65%493,571-15,334-3.01%785,000Mar 31, 2024
STONEPINE CAPITAL MANAGEMENT, LLC2.16%0.49%384,600-285,084-42.57%611,514Mar 31, 2024
PENBROOK MANAGEMENT LLC0.43%0.08%76,7101,0001.32%121,969Mar 31, 2024
COWEN AND COMPANY, LLC5.04%0.06%898,630--1,428,821Mar 31, 2024
RTW INVESTMENTS, LP8.44%0.04%1,504,602--2,392,317Mar 31, 2024
PALUMBO WEALTH MANAGEMENT LLC0.10%0.01%18,24118,241100.00%29,004Mar 31, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.42%0.01%74,306-22,818-23.49%118,147Mar 31, 2024
WASATCH ADVISORS LP4.41%0.01%786,895-63,413-7.46%1,251,163Mar 31, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC3.05%0.01%544,877--866,354Mar 31, 2024
FIRST BANK & TRUST0.08%0.00%13,518--21,494Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.23%0.00%40,800--64,872Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.02%0.00%4,006-946-19.10%6,369Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.27%0.00%48,7583,2707.19%78,000Mar 31, 2024
ALLWORTH FINANCIAL LP0.04%0.00%7,015--11,154,000Mar 31, 2024
MORGAN STANLEY2.70%0.00%482,420-1,500-0.31%767,048Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.11%-19,8009,20086.79%31,482Mar 31, 2024
UBS GROUP AG0.35%-62,5161070.17%99,400Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.13%-23,8602451.04%37,937Mar 31, 2024
VANGUARD GROUP INC2.75%-490,944--780,601Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.46%-81,583--129,757Mar 31, 2024

The largest Exagen shareholder by % of total assets is PERKINS CAPITAL MANAGEMENT INC. The company owns 493.57K shares of Exagen (XGN), representing 0.65% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PALUMBO WEALTH MANAGEMENT LLC0.10%0.01%18,24118,241100.00%29,004Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.11%-19,8009,20086.79%31,482Mar 31, 2024
CITADEL ADVISORS LLC0.02%-4,1003,9001950.00%6,519Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.27%0.00%48,7583,2707.19%78,000Mar 31, 2024
CITADEL ADVISORS LLC0.01%-1,6001,5001500.00%2,544Mar 31, 2024
PENBROOK MANAGEMENT LLC0.43%0.08%76,7101,0001.32%121,969Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.13%-23,8602451.04%37,937Mar 31, 2024
UBS GROUP AG0.35%-62,5161070.17%99,400Mar 31, 2024
JPMORGAN CHASE & CO0.00%-34936.00%54Mar 31, 2024
WELLS FARGO & COMPANY/MN0.01%-2,45710.04%3,906,000Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-204--324Mar 31, 2024
BARCLAYS PLC0.03%-5,145--8,000Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.46%-81,583--129,757Mar 31, 2024
VANGUARD GROUP INC2.75%-490,944--780,601Mar 31, 2024
ALLWORTH FINANCIAL LP0.04%0.00%7,015--11,154,000Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.23%0.00%40,800--64,872Mar 31, 2024
FIRST BANK & TRUST0.08%0.00%13,518--21,494Mar 31, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC3.05%0.01%544,877--866,354Mar 31, 2024
RTW INVESTMENTS, LP8.44%0.04%1,504,602--2,392,317Mar 31, 2024
COWEN AND COMPANY, LLC5.04%0.06%898,630--1,428,821Mar 31, 2024

As of Mar 31 2024, Exagen's largest institutional buyer is PALUMBO WEALTH MANAGEMENT LLC. The company purchased 18.24K stocks of XGN, valued at $29.00K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STONEPINE CAPITAL MANAGEMENT, LLC2.16%0.49%384,600-285,084-42.57%611,514Mar 31, 2024
WASATCH ADVISORS LP4.41%0.01%786,895-63,413-7.46%1,251,163Mar 31, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.42%0.01%74,306-22,818-23.49%118,147Mar 31, 2024
PERKINS CAPITAL MANAGEMENT INC2.77%0.65%493,571-15,334-3.01%785,000Mar 31, 2024
CITADEL ADVISORS LLC0.04%-7,240-13,495-65.08%11,512Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.15%-26,437-9,593-26.63%42,035Mar 31, 2024
STATE STREET CORP0.16%-27,691-6,000-17.81%44,029Mar 31, 2024
BLACKROCK INC.0.31%-55,505-2,330-4.03%88,253Mar 31, 2024
MORGAN STANLEY2.70%0.00%482,420-1,500-0.31%767,048Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.02%0.00%4,006-946-19.10%6,369Mar 31, 2024
ROYAL BANK OF CANADA----542-100.00%-Mar 31, 2024
NORTHERN TRUST CORP0.09%-16,370-70-0.43%26,029Mar 31, 2024
BANK OF AMERICA CORP /DE/0.03%-6,019-7-0.12%9,570,000Mar 31, 2024
COWEN AND COMPANY, LLC5.04%0.06%898,630--1,428,821Mar 31, 2024
RTW INVESTMENTS, LP8.44%0.04%1,504,602--2,392,317Mar 31, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC3.05%0.01%544,877--866,354Mar 31, 2024
FIRST BANK & TRUST0.08%0.00%13,518--21,494Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.23%0.00%40,800--64,872Mar 31, 2024
ALLWORTH FINANCIAL LP0.04%0.00%7,015--11,154,000Mar 31, 2024
VANGUARD GROUP INC2.75%-490,944--780,601Mar 31, 2024

As of Mar 31 2024, Exagen's biggest institutional seller is STONEPINE CAPITAL MANAGEMENT, LLC. The company sold -0.29M shares of XGN, valued at $611.51K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PALUMBO WEALTH MANAGEMENT LLC0.10%0.01%18,24118,241100.00%29,004Mar 31, 2024

Exagen's largest new institutional shareholder by number of shares is PALUMBO WEALTH MANAGEMENT LLC, purchased 18.24K shares, valued at $29.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ROYAL BANK OF CANADA----542-100.00%-Mar 31, 2024

Exagen's largest sold out institutional shareholder by shares sold is ROYAL BANK OF CANADA, sold -0.54K shares, valued at -, as of undefined.

Exagen Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
NEIMAN FUNDS0.27%47,600--Dec 31, 2023
PARADIGM FUNDS0.27%81,189--Dec 31, 2023
WASATCH FUNDS TRUST0.08%744,314-63,639-7.88%Mar 31, 2024
World Funds Trust0.03%16,500--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.02%8,667--Dec 31, 2023
AMG Funds I0.02%25,133--Jan 31, 2024
BRIDGEWAY FUNDS INC0.02%39,000--Dec 29, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%1,684--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.00%20,018--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%610,168141,95130.32%Dec 31, 2023
VICTORY PORTFOLIOS0.00%36,345--Dec 31, 2023
Fidelity Commonwealth Trust II0.00%4,062--Aug 31, 2023
CALAMOS INVESTMENT TRUST/IL0.00%48,210--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%75,130-336-0.45%Feb 29, 2024
Calvert Variable Products, Inc.0.00%849--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%9,919--Dec 31, 2023
Meeder Funds0.00%1,351--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,753--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%594--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%303--Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%4,095--Feb 29, 2024
SunAmerica Specialty Series0.00%39--Apr 30, 2021
ALLSPRING MASTER TRUST0.00%3,737--Feb 29, 2024
PACE SELECT ADVISORS TRUST0.00%12,869--Jan 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%3,265--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%74,950--Feb 29, 2024
ProFunds0.00%220--Jan 31, 2024
RYDEX SERIES FUNDS0.00%98--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%1,900--Dec 31, 2023
PENN SERIES FUNDS INC0.00%500--Dec 29, 2023
VANGUARD SCOTTSDALE FUNDS0.00%34,956--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%303--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%14,987-9,504-38.81%Jan 31, 2024
RYDEX DYNAMIC FUNDS0.00%55--Dec 31, 2023
VALIC Co I0.00%3,826--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%1,343--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%61--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%1,348--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%10--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%8,599--Dec 31, 2023
NORTHERN FUNDS0.00%5,582--Dec 29, 2023
PROSHARES TRUST0.00%1,485--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%487--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%8,800--Dec 31, 2023
T. Rowe Price Multi-Strategy Total Return Fund, Inc.0.00%552--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%1,138--Jan 31, 2024
HC CAPITAL TRUST0.00%81--Dec 31, 2023
PACIFIC SELECT FUND0.00%5,287--Dec 31, 2023
EQ ADVISORS TRUST0.00%1,695--Dec 31, 2023
iSHARES TRUST0.00%21,461--Feb 29, 2024
MASSMUTUAL SELECT FUNDS0.00%771--Dec 31, 2023
Bridge Builder Trust0.00%3,243--Dec 31, 2023
BLACKROCK FUNDS0.00%2,519--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%1,395--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%3--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%962--Feb 29, 2024

Exagen's largest mutual fund holder by % of total assets is "NEIMAN FUNDS", owning 47.60K shares, compromising 0.27% of its total assets.

Exagen Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2432-
31 Dec, 233210.34%
30 Sep, 23293.57%
30 Jun, 2328-
31 Mar, 2328-6.67%
31 Dec, 2230-21.05%
30 Sep, 2238-17.39%
30 Jun, 2246-14.81%
31 Mar, 22543.85%
31 Dec, 2152-3.70%
30 Sep, 2154-
30 Jun, 2154-3.57%
31 Mar, 215660.00%
31 Dec, 20352.94%
30 Sep, 20343.03%
30 Jun, 20333.13%
31 Mar, 2032-11.11%
31 Dec, 193633.33%
30 Sep, 1927-

As of 31 Mar 24, 32 institutions are holding Exagen's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 246,204,754-5.90%
31 Dec, 236,593,813-3.96%
30 Sep, 236,865,400-0.25%
30 Jun, 236,882,6880.74%
31 Mar, 236,831,970-1.50%
31 Dec, 226,936,247-12.54%
30 Sep, 227,930,778-25.90%
30 Jun, 2210,703,47917.75%
31 Mar, 229,090,3235.68%
31 Dec, 218,601,827-2.05%
30 Sep, 218,782,0201.95%
30 Jun, 218,614,043-2.93%
31 Mar, 218,873,91097.82%
31 Dec, 204,485,9134.86%
30 Sep, 204,278,08018.56%
30 Jun, 203,608,357-6.87%
31 Mar, 203,874,6880.77%
31 Dec, 193,845,0397.26%
30 Sep, 193,584,885-

Exagen (XGN) has 6.20M shares outstanding as of 31 Mar 24, down -5.90% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2434.79%2.50%
31 Dec, 2337.27%2.46%
30 Sep, 2338.89%2.52%
30 Jun, 2339.27%2.58%
31 Mar, 2338.98%2.36%
31 Dec, 2240.60%1.88%
30 Sep, 2246.43%1.18%
30 Jun, 2262.75%2.19%
31 Mar, 2253.50%1.84%
31 Dec, 2153.85%2.01%
30 Sep, 2151.82%2.00%
30 Jun, 2150.88%1.08%
31 Mar, 2168.56%5.44%
31 Dec, 2035.51%3.10%
30 Sep, 2033.83%4.15%
30 Jun, 2028.55%3.02%
31 Mar, 2030.76%3.28%
31 Dec, 1930.61%3.76%
30 Sep, 1928.54%-

As of 31 Mar 24, Exagen is held by 34.79% institutional shareholders, representing a 2.50% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 248-11.11%
31 Dec, 239-
30 Sep, 239-18.18%
30 Jun, 231137.50%
31 Mar, 238-
31 Dec, 228-46.67%
30 Sep, 2215-
30 Jun, 2215-37.50%
31 Mar, 22244.35%
31 Dec, 2123-8.00%
30 Sep, 2125-26.47%
30 Jun, 2134-17.07%
31 Mar, 2141156.25%
31 Dec, 201633.33%
30 Sep, 2012-36.84%
30 Jun, 20195.56%
31 Mar, 2018-40.00%
31 Dec, 193011.11%
30 Sep, 1927-

8 institutional shareholders have increased their position in XGN stock as of 31 Mar 24 compared to 9 in the previous quarter (a -11.11% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24129.09%
31 Dec, 231137.50%
30 Sep, 23833.33%
30 Jun, 236-25.00%
31 Mar, 238-55.56%
31 Dec, 221828.57%
30 Sep, 2214-46.15%
30 Jun, 222630.00%
31 Mar, 222025.00%
31 Dec, 2116-15.79%
30 Sep, 211918.75%
30 Jun, 211660.00%
31 Mar, 2110-
31 Dec, 2010-41.18%
30 Sep, 201788.89%
30 Jun, 209-18.18%
31 Mar, 2011120.00%
31 Dec, 195-
30 Sep, 19--

12 institutional shareholders have reduced their position in XGN stock as of 31 Mar 24 compared to 11 in the previous quarter (a 9.09% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2432-6,204,754-5.90%34.79%2.50%8-11.11%129.09%
31 Dec, 233210.34%6,593,813-3.96%37.27%2.46%9-1137.50%
30 Sep, 23293.57%6,865,400-0.25%38.89%2.52%9-18.18%833.33%
30 Jun, 2328-6,882,6880.74%39.27%2.58%1137.50%6-25.00%
31 Mar, 2328-6.67%6,831,970-1.50%38.98%2.36%8-8-55.56%
31 Dec, 2230-21.05%6,936,247-12.54%40.60%1.88%8-46.67%1828.57%
30 Sep, 2238-17.39%7,930,778-25.90%46.43%1.18%15-14-46.15%
30 Jun, 2246-14.81%10,703,47917.75%62.75%2.19%15-37.50%2630.00%
31 Mar, 22543.85%9,090,3235.68%53.50%1.84%244.35%2025.00%
31 Dec, 2152-3.70%8,601,827-2.05%53.85%2.01%23-8.00%16-15.79%
30 Sep, 2154-8,782,0201.95%51.82%2.00%25-26.47%1918.75%
30 Jun, 2154-3.57%8,614,043-2.93%50.88%1.08%34-17.07%1660.00%
31 Mar, 215660.00%8,873,91097.82%68.56%5.44%41156.25%10-
31 Dec, 20352.94%4,485,9134.86%35.51%3.10%1633.33%10-41.18%
30 Sep, 20343.03%4,278,08018.56%33.83%4.15%12-36.84%1788.89%
30 Jun, 20333.13%3,608,357-6.87%28.55%3.02%195.56%9-18.18%
31 Mar, 2032-11.11%3,874,6880.77%30.76%3.28%18-40.00%11120.00%
31 Dec, 193633.33%3,845,0397.26%30.61%3.76%3011.11%5-
30 Sep, 1927-3,584,885-28.54%-27---

Exagen Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024ABALLI JOHNdirector, officer President and CEOP-PurchaseBuy40,401$1.92$77.57K40,401
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell9,297$1.91$17.75K247,236
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,487$1.91$6.66K243,749
Feb 08, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell6,738$1.95$13.13K181,533
Oct 18, 2023ABALLI JOHNdirector, officer President and CEOS-SaleSell33,819$1.75$59.02K415,984
Jun 20, 2023TULLIS JAMES L L10 percent owner-P-PurchaseBuy167$3.11$519.451,515,839
Mar 03, 2023Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,667$2.30$8.43K188,271
Mar 03, 2023Hazeltine Markofficer Chief Business OfficerS-SaleSell3,667--190,205

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024ABALLI JOHNdirector, officer President and CEOP-PurchaseBuy40,401$1.92$77.57K40,401
Jun 20, 2023TULLIS JAMES L L10 percent owner-P-PurchaseBuy167$3.11$519.451,515,839

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell9,297$1.91$17.75K247,236
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,487$1.91$6.66K243,749
Feb 08, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell6,738$1.95$13.13K181,533
Oct 18, 2023ABALLI JOHNdirector, officer President and CEOS-SaleSell33,819$1.75$59.02K415,984
Mar 03, 2023Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,667$2.30$8.43K188,271
Mar 03, 2023Hazeltine Markofficer Chief Business OfficerS-SaleSell3,667--190,205

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024ABALLI JOHNdirector, officer President and CEOP-PurchaseBuy40,401$1.92$77.57K40,401
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell9,297$1.91$17.75K247,236
Mar 06, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,487$1.91$6.66K243,749
Mar 04, 2024ABALLI JOHNdirector, officer President and CEOA-AwardBuy9,804$1.91$18.73K600,788
Feb 22, 2024Adawi Kamalofficer CFO and Corporate SecretaryA-AwardBuy75,000--256,533
Feb 22, 2024ABALLI JOHNdirector, officer President and CEOA-AwardBuy175,000--590,984
Feb 08, 2024Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell6,738$1.95$13.13K181,533
Oct 18, 2023ABALLI JOHNdirector, officer President and CEOS-SaleSell33,819$1.75$59.02K415,984
Sep 06, 2023ABALLI JOHNdirector, officer President and CEOA-AwardBuy9,803$2.14$21.00K449,803
Jul 26, 2023Kim Pauldirector-A-AwardBuy15,000$2.59$38.83K15,000
Jul 26, 2023Kim Pauldirector Buy----
Jun 20, 2023TULLIS JAMES L L10 percent owner-P-PurchaseBuy167$3.11$519.451,515,839
Jun 20, 2023Nova Tina Susandirector, officer Executive ChairpersonA-AwardBuy13,500$3.22$43.47K13,500
Jun 13, 2023Stokes Frankdirector-A-AwardBuy9,000$3.13$28.17K9,000
Jun 13, 2023Birk Briandirector-A-AwardBuy9,000$3.13$28.17K9,000
Jun 13, 2023PALLARES EBETUELdirector-A-AwardBuy9,000$3.13$28.17K9,000
Jun 13, 2023Hooker Anadirector-A-AwardBuy9,000$3.13$28.17K9,000
Jun 13, 2023Johnson Wendy S.director-A-AwardBuy9,000$3.13$28.17K9,000
Mar 03, 2023Adawi Kamalofficer CFO and Corporate SecretaryS-SaleSell3,667$2.30$8.43K188,271
Mar 03, 2023Hazeltine Markofficer Chief Business OfficerS-SaleSell3,667--190,205

The last insider sell of Exagen's stock was made by Adawi Kamal on Mar 06 2024, selling 9,297 shares at $1.91 per share (valued at $17.75K). The last insider buy of XGN was made by ABALLI JOHN on May 16 2024, buying 40,401 shares at $1.92 per share (worth $77.57K).

Exagen Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241--
Q1 202433100.00%
Q4 2023-1-
Q3 20232--
Q2 20237--
Q1 20232450.00%
Q4 20222--
Q2 202212--
Q1 202244100.00%
Q3 20212450.00%
Q2 202184200.00%
Q1 202162030.00%
Q4 20201119.09%
Q3 2020-5-
Q2 2020109111.11%
Q1 202055100.00%
Q3 2019234156.10%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Exagen's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241--
Q1 2024-3-
Q4 2023-1-
Q3 2023---
Q2 20231--
Q1 2023-4-
Q4 20221--
Q2 2022---
Q1 2022---
Q3 20211425.00%
Q2 2021-3-
Q1 2021-14-
Q4 2020-11-
Q3 2020-5-
Q2 2020-7-
Q1 2020---
Q3 20191--

As of Q2 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Exagen's stocks.

Exagen Peer Ownership


TickerCompany
FONRFONAR Corporation
GTHGenetron Holdings Limited
BNRBurning Rock Biotech Limited
SHCSotera Health Company
DRIODarioHealth Corp.
CSTLCastle Biosciences, Inc.
LMDXLumiraDx Limited
PMDPsychemedics Corporation
BDSXBiodesix, Inc.
OLKOlink Holding AB (publ)
SERASera Prognostics, Inc.

XGN Ownership FAQ


Exagen is owned by institutional shareholders (34.79%), insiders (28.31%), and public (36.90%). The largest institutional shareholder of Exagen is RTW INVESTMENTS, LP (8.44% of total shares) and the top mutual fund owner is NEIMAN FUNDS (0.27% of total shares).

Exagen's major institutional shareholders are RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, WASATCH ADVISORS LP, SILVERCREST ASSET MANAGEMENT GROUP LLC, and PERKINS CAPITAL MANAGEMENT INC. The top five shareholders own together 23.71% of the company's share outstanding.

As of Mar 2024, there are 32 institutional shareholders of Exagen.

RTW INVESTMENTS, LP owns 1.5M shares of Exagen, representing 8.44% of the company's total shares outstanding, valued at $2.39M (as of Mar 2024).

As of Mar 2024, COWEN AND COMPANY, LLC holds 898.63K shares of Exagen (XGN), compromising 5.04% of the company, valued at $1.43M.

WASATCH ADVISORS LP is the third largest holder of Exagen. The company owns 786.9K of the company's shares outstanding (worth $1.25M).